508 related articles for article (PubMed ID: 32949888)
1. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
Zheng S; Baak JP; Li S; Xiao W; Ren H; Yang H; Gan Y; Wen C
Phytomedicine; 2020 Dec; 79():153336. PubMed ID: 32949888
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.
Kong Q; Wu Y; Gu Y; Lv Q; Qi F; Gong S; Chen X
Biomed Pharmacother; 2020 Aug; 128():110316. PubMed ID: 32505821
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
4. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
Gao LQ; Xu J; Chen SD
Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
[TBL] [Abstract][Full Text] [Related]
5. [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
Niu M; Wang RL; Wang ZX; Zhang P; Bai ZF; Jing J; Guo YM; Zhao X; Zhan XY; Zhang ZT; Song XA; Qin EQ; Wang JB; Xiao XH
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1213-1218. PubMed ID: 32281327
[TBL] [Abstract][Full Text] [Related]
6. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
7. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
[TBL] [Abstract][Full Text] [Related]
8. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS
Zhang ZJ; Wu WY; Hou JJ; Zhang LL; Li FF; Gao L; Wu XD; Shi JY; Zhang R; Long HL; Lei M; Wu WY; Guo DA; Chen KX; Hofmann LA; Ci ZH
J Integr Med; 2020 May; 18(3):229-241. PubMed ID: 32307268
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
[TBL] [Abstract][Full Text] [Related]
10. Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs.
Zhong LLD; Lam WC; Yang W; Chan KW; Sze SCW; Miao J; Yung KKL; Bian Z; Wong VT
Am J Chin Med; 2020; 48(5):1051-1071. PubMed ID: 32668969
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19.
Zhang X; Gao R; Zhou Z; Tang X; Lin J; Wang L; Zhou X; Shen T
Int J Med Sci; 2021; 18(8):1866-1876. PubMed ID: 33746604
[TBL] [Abstract][Full Text] [Related]
12. New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment.
Tianyu Z; Xiaoli C; Yaru W; Min Z; Fengli Y; Kan H; Li C; Jing L
Aging (Albany NY); 2021 Nov; 13(21):23913-23935. PubMed ID: 34731090
[TBL] [Abstract][Full Text] [Related]
13. [Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].
Ma J; Huo XQ; Chen X; Zhu WX; Yao MC; Qiao YJ; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1219-1224. PubMed ID: 32281328
[TBL] [Abstract][Full Text] [Related]
14. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
15. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.
Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ
J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology].
Wang Y; Li X; Zhang JH; Xue R; Qian JY; Zhang XH; Zhang H; Liu QQ; Fan XH; Cheng YY; Zhang BL
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2249-2256. PubMed ID: 32495577
[TBL] [Abstract][Full Text] [Related]
17. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
Nicolau LAD; Magalhães PJC; Vale ML
Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
[TBL] [Abstract][Full Text] [Related]
18. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
[TBL] [Abstract][Full Text] [Related]
19. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
20. [Exploration on scientific connotation of TCM syndromes and recommended prescriptions against COVID-19 based on TCMTP V2.0].
Xu HY; Zhang YQ; Qing YW; Zhao HY; Wang P; Liu F
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1488-1498. PubMed ID: 32489025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
